Total Payments
$95,463
2024 Payments
$527.86
Companies
22
Transactions
135
Medicare Patients
398
Medicare Billing
$39,708
Payment Breakdown by Category
Other$43,877 (46.0%)
Consulting$22,250 (23.3%)
Research$15,344 (16.1%)
Travel$9,289 (9.7%)
Food & Beverage$4,402 (4.6%)
Education$299.45 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33,509 | 14 | 35.1% |
| Consulting Fee | $22,250 | 10 | 23.3% |
| Unspecified | $15,344 | 9 | 16.1% |
| Honoraria | $10,369 | 6 | 10.9% |
| Travel and Lodging | $9,289 | 19 | 9.7% |
| Food and Beverage | $4,402 | 74 | 4.6% |
| Education | $299.45 | 3 | 0.3% |
Payments by Type
General
$80,118
126 transactions
Research
$15,344
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $40,871 | 23 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $34,125 | 38 | $0 (2024) |
| Adamas Pharmaceuticals, Inc. | $12,587 | 9 | $0 (2018) |
| Acorda Therapeutics, Inc | $2,249 | 10 | $0 (2024) |
| Sage Therapeutics, Inc. | $2,042 | 5 | $0 (2023) |
| Lundbeck LLC | $1,463 | 8 | $0 (2019) |
| UCB, Inc. | $1,069 | 7 | $0 (2024) |
| ABBVIE INC. | $338.99 | 14 | $0 (2024) |
| Medtronic USA, Inc. | $144.13 | 2 | $0 (2018) |
| Ipsen Biopharmaceuticals, Inc | $139.46 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $527.86 | 14 | ACADIA Pharmaceuticals Inc ($116.16) |
| 2023 | $3,269 | 18 | Sage Therapeutics, Inc. ($2,042) |
| 2022 | $465.00 | 9 | Teva Pharmaceuticals USA, Inc. ($335.17) |
| 2021 | $331.33 | 8 | Teva Pharmaceuticals USA, Inc. ($219.33) |
| 2020 | $6,037 | 4 | ACADIA Pharmaceuticals Inc ($6,000) |
| 2019 | $9,454 | 14 | ACADIA Pharmaceuticals Inc ($8,000) |
| 2018 | $38,570 | 35 | ACADIA Pharmaceuticals Inc ($17,107) |
| 2017 | $36,807 | 33 | Teva Pharmaceuticals USA, Inc. ($24,783) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/22/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $89.00 | General |
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Central Nervous System | ||||||
| 11/05/2024 | ARGENX US, INC. | VYVGART (Drug), VYVGART HYTRULO | Food and Beverage | In-kind items and services | $34.46 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: NEUROLOGY | ||||||
| 10/02/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $100.80 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/28/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $114.49 | General |
| Category: Neurology | ||||||
| 08/21/2024 | Amneal Pharmaceuticals LLC | ONGENTYS 50MG CAPSULES 30 (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: NEUROLOGY | ||||||
| 08/03/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: Neurology | ||||||
| 06/19/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/17/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Neurology | ||||||
| 04/02/2024 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Parkinson's Disease | ||||||
| 03/13/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/22/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Neurology | ||||||
| 11/09/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Parkinson's Disease | ||||||
| 11/09/2023 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2023 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $609.08 | General |
| 10/27/2023 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $252.70 | General |
| 10/27/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $68.69 | General |
| 10/27/2023 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $54.32 | General |
| 10/27/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $49.84 | General |
| 08/03/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/31/2023 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACA 16-cAC-0001 | ACADIA Pharmaceuticals Inc | $14,000 | 6 |
| Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension RESTORE | Lundbeck LLC | $1,344 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 75 | 115 | $15,428 | $7,914 |
| 2022 | 4 | 112 | 145 | $21,286 | $10,644 |
| 2021 | 3 | 81 | 105 | $19,188 | $9,912 |
| 2020 | 5 | 130 | 177 | $26,411 | $11,237 |
Total Patients
398
Total Services
542
Medicare Billing
$39,708
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 64 | $10,880 | $5,804 | 53.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 12 | $2,832 | $1,602 | 56.6% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 15 | 39 | $1,716 | $508.52 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 63 | $10,710 | $5,422 | 50.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 29 | $6,844 | $3,606 | 52.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 20 | $2,280 | $1,202 | 52.7% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2022 | 14 | 33 | $1,452 | $414.24 | 28.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 57 | $9,690 | $4,639 | 47.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 27 | 33 | $7,788 | $4,396 | 56.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 15 | $1,710 | $876.99 | 51.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 76 | 97 | $16,490 | $6,959 | 42.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 16 | 18 | $4,248 | $1,934 | 45.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 11 | 11 | $2,519 | $1,227 | 48.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 13 | $1,482 | $590.52 | 39.8% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Facility | 2020 | 14 | 38 | $1,672 | $526.72 | 31.5% |
About Dr. John Goudreau, D.O
Dr. John Goudreau, D.O is a Neurology healthcare provider based in East Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477563096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Goudreau, D.O has received a total of $95,463 in payments from pharmaceutical and medical device companies, with $527.86 received in 2024. These payments were reported across 135 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($33,509).
As a Medicare-enrolled provider, Goudreau has provided services to 398 Medicare beneficiaries, totaling 542 services with total Medicare billing of $39,708. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location East Lansing, MI
- Active Since 08/08/2006
- Last Updated 08/29/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1477563096
Products in Payments
- NUPLAZID (Drug) $40,871
- AUSTEDO (Drug) $29,531
- GOCOVRI (Drug) $12,587
- SD809-HD (Drug) $3,716
- NORTHERA (Drug) $1,463
- SD809-TD (Drug) $562.95
- DUOPA (Drug) $171.02
- ACTIVA (Device) $161.42
- INBRIJA (Drug) $132.96
- Duopa (Drug) $114.72
- Dysport (Drug) $114.49
- RYTARY (Drug) $101.67
- APOKYN (Drug) $57.06
- BOTOX (Biological) $53.25
- NOURIANZ (Drug) $34.49
- VYVGART (Drug) $34.46
- Briviact (Drug) $34.24
- Infinity DBS Pulse Generators (Device) $31.82
- Sunosi (Drug) $29.43
- Epidiolex (Drug) $26.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in East Lansing
Dr. Mounzer Yassin-Kassab, M.d, M.D
Neurology — Payments: $386,102
Neurology $386,102
Dr. Jayne Ward, D.o, D.O
Neurology — Payments: $366,840
Neurology $366,840
Dr. Amit Sachdev, M.d., Ms, M.D., MS
Neurology — Payments: $292,376
Neurology $292,376
Dr. Tariq Gheith, M.d, M.D
Neurology — Payments: $218,666
Neurology $218,666
Dr. Larry Charleston, M.d, M.D
Neurology — Payments: $211,437
Neurology $211,437
Dr. Anmar Razak, M.d, M.D
Neurology — Payments: $146,635
Neurology $146,635